Conduit Pharmaceuticals Inc. (CDTTW) — SC 13G/A Filings
All SC 13G/A filings from Conduit Pharmaceuticals Inc.. Browse 7 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (7)
- SC 13G/A Filing — Nov 6, 2024
- SC 13G/A Filing — Oct 18, 2024
- SC 13G/A Filing — Oct 7, 2024
- SC 13G/A Filing — Aug 13, 2024
-
Polar Asset Mgmt. Reports 1.3% Stake in Conduit Pharma
— Feb 12, 2024 Risk: low
Polar Asset Management Partners Inc. filed an amended SC 13G/A on February 12, 2024, reporting a beneficial ownership of 950,000 shares of Conduit Pharmaceutica -
Saba Capital Maintains Stake in Conduit Pharma as of Dec 31, 2023
— Feb 8, 2024 Risk: low
Saba Capital Management, L.P. filed an amended SC 13G/A on February 8, 2024, indicating their ownership of Conduit Pharmaceuticals Inc. common stock as of Decem -
Hudson Bay Capital Reports 9.9% Stake in Conduit Pharma
— Feb 2, 2024
Hudson Bay Capital Management LP, a hedge fund, has updated its ownership stake in Conduit Pharmaceuticals Inc. (formerly Murphy Canyon Acquisition Corp.) as of
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX